Global Pharmaceutical Industry Outlook, 2023

Global Pharmaceutical Industry Outlook, 2023

Transformative Megatrends are Expanding the Vendor Ecosystem

RELEASE DATE
27-Mar-2023
REGION
Global
Research Code: PE5D-01-00-00-00
SKU: HC03649-GL-MO_27529
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC03649-GL-MO_27529
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the Asia-Pacific, Latin America, and the Rest of the World. Inflation will continue to be a pressing challenge for the pharmaceutical industry in 2023, affecting returns on investment. Pharmaceutical companies will continue to shift towards regional rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain. There will be a strong focus on environmental, social, and governance (ESG) commitments and supply-chain digitalization through lighthouse manufacturing techniques, decentralized clinical trial (DCT) approaches, and the application of artificial intelligence (AI). The study segments the pharmaceutical industry into two key segments, namely, chemicals/small molecules and biologics. It covers the following:
• An overview of the pharmaceutical industry
• Revenue forecasts by segment
• Top 5 predictions for the industry for 2023 and beyond
• Key macro and micro trends driving the future of the industry
• Research and development (R&D) expenditure and key therapeutic areas for 2023 and beyond
• Growth opportunities emerging from this space for stakeholders and market players to leverage

Author: Surbhi Gupta

Table of Contents

Key Highlights

Top Predictions for 2023

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the Global Pharmaceutical Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Segmentation and Scope

Key Trend 1: Adoption of Lighthouse Manufacturing Techniques

Key Trend 1: Adoption of Lighthouse Manufacturing Techniques (continued)

Key Trend 2: Increased Focus on Fulfilling ESG Commitments

Key Trend 2: Increased Focus on Fulfilling ESG Commitments (continued)

Key Trend 3: Increased Application of AI across the Pharma Value Chain

Key Trend 3: Increased Application of AI across the Pharma Value Chain (continued)

Key Trend 4: Intensification of Skilled Workforce Challenges

Key Trend 4: Intensification of Skilled Workforce Challenges (continued)

Global Pharmaceutical Industry: R&D Expenditure Outlook

Global Drug Development Pipeline by Clinical Phase

Key Therapeutic Areas Outlook

Top 5 Global Economic Highlights of 2022

Top 5 Global Economic Highlights of 2023

Global GDP Growth Expectations

Recessionary/Slowdown Expectations for Major Economies

Global GDP Growth Snapshot

Advanced Economy Predictions for 2023

Emerging Market Economy Predictions for 2023

2023 Regional Risks and Policy Direction

2023 Top Growth Opportunities by Region

Right Shoring vs. Reshoring: Impact Analysis

Right Shoring vs. Reshoring: Impact Analysis (continued)

Rising Inflation: Impact Analysis

Rising Inflation: Impact Analysis (continued)

Global Pharmaceutical Industry: Historic Sales and Forecast

Segment Performance: Historic Sales and Forecast

Revenue Forecast by Region

Regulatory Regional Trends: North America

Regulatory Regional Trends: Europe

Regulatory Regional Trends: Asia-Pacific, Latin America, the Middle East and Africa

Prediction 1

Prediction 2

Prediction 3

Prediction 4

Prediction 5

Small Molecules Snapshot, 2023

Small Molecules: Companies to Watch

Biologics Snapshot, 2023

Biologics Snapshot: Companies to Watch

Growth Opportunity 1: Drug and Software-as-a-Medical-Device (SaMD) Combination Products and Platforms

Growth Opportunity 1: Drug and Software-as-a-Medical-Device (SaMD) Combination Products and Platforms (continued)

Growth Opportunity 2: Dual and Multi-targeting Antibodies for Immuno-oncology

Growth Opportunity 2: Dual and Multi-targeting Antibodies for Immuno-oncology (continued)

Growth Opportunity 3: Strategic CGT Partnerships between Academia, CDMOs, and Biopharma Companies in the EU

Growth Opportunity 3: Strategic CGT Partnerships between Academia, CDMOs, and Biopharma Companies in the EU (continued)

Key Conclusions

Market Definition: Pharmaceuticals and Biotechnology

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the Asia-Pacific, Latin America, and the Rest of the World. Inflation will continue to be a pressing challenge for the pharmaceutical industry in 2023, affecting returns on investment. Pharmaceutical companies will continue to shift towards regional rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain. There will be a strong focus on environmental, social, and governance (ESG) commitments and supply-chain digitalization through lighthouse manufacturing techniques, decentralized clinical trial (DCT) approaches, and the application of artificial intelligence (AI). The study segments the pharmaceutical industry into two key segments, namely, chemicals/small molecules and biologics. It covers the following: • An overview of the pharmaceutical industry • Revenue forecasts by segment • Top 5 predictions for the industry for 2023 and beyond • Key macro and micro trends driving the future of the industry • Research and development (R&D) expenditure and key therapeutic areas for 2023 and beyond • Growth opportunities emerging from this space for stakeholders and market players to leverage Author: Surbhi Gupta
More Information
Author Surbhi Gupta
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Pharmaceutical Market Trends
Keyword 2 Pharmaceutical Market Forecast
Keyword 3 future trends in pharmaceutical industry
Podcast No
Predecessor PCC8-01-00-00-00
WIP Number PE5D-01-00-00-00